New vasoactive peptides in cirrhosis: organ extraction and relation to the vasodilatory state

Authors

  • Nina Kimer,

    1. Department of Clinical Physiology and Nuclear Medicine, Center for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark
    2. Gastro Unit, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark
    Search for more papers by this author
  • Jens Peter Goetze,

    1. Department of Clinical Biochemistry, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
    Search for more papers by this author
  • Flemming Bendtsen,

    1. Gastro Unit, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark
    Search for more papers by this author
  • Søren Møller

    Corresponding author
    1. Department of Clinical Physiology and Nuclear Medicine, Center for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark
    • Correspondence to: Søren Møller, Department of Clinical Physiology and Nuclear Medicine, 239, Copenhagen University Hospital Hvidovre, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark. Tel.: +45 32 68 35 68; fax: +45 3862 3750;

      e-mail: soeren.moeller@regionh.dk

    Search for more papers by this author

Abstract

Background

Patients with cirrhosis have substantial circulatory imbalance between vasoconstrictive and vasodilating forces. The study of circulatory vasoactive peptides may provide important pathophysiological information. This study aimed to assess concentrations, organ extraction and relations to haemodynamic changes in the pro-peptides copeptin, proadrenomedullin and pro-atrial natriuretic peptide (proANP) in patients with cirrhosis.

Materials and methods

Fifty-four cirrhotic patients and 15 controls were characterized haemodynamically during a liver vein catheterization. Copeptin, proadrenomedullin and proANP were measured in hepatic and renal veins and the femoral artery.

Results

We found no differences in concentrations of copeptin and proadrenomedullin between patients and controls. ProANPs were higher in cirrhotic patients, median 138 pm (25/75 percentiles 101–194) compared with controls, median 91 pm (25/75 percentiles 82–153) = 0·02. ProANPs were higher in the femoral artery and renal vein, median 140 pm and 116 pm (25/75 percentiles 109–191 and 92–164, respectively), compared with controls, median 99 and 81 (25/75 percentiles 85–146 and 66–123) = 0·02 and = 0·007, respectively. We found no extraction of copeptin, proadrenomedullin or proANP over the liver. Copeptin correlated with portal pressure (R = 0·50, < 0·001). Proadrenomedullin correlated with portal pressure (R = 0·48, < 0·001) and heart rate (R = 0·36, < 0·01). ProANP correlated with cardiac output (R = 0·46, < 0·002) and portal pressure (R = 0·32, < 0·02). All propeptides correlated with Child score (R > 0·31, < 0·03).

Conclusions

Pro-atrial natriuretic peptide is elevated in cirrhosis. Copeptin, proadrenomedullin and proANP are related to portal pressure and seem associated with systemic haemodynamics. These propeptides may participate in development and perpetuation of vasodilatation and hyperdynamic circulation in cirrhosis.

Ancillary